Results show AI is getting twice as good at the rate of about every seven months and experts say the trend is speeding up.

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...